⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 20, 2024

[Dihydroartemisinin enhances sensitivity of nasopharyngeal carcinoma HNE1/DDP cells to cisplatin-induced apoptosis by promoting ROS production].

Xianling Cong Tian Chen Shujun Li Ying Wang Liang Zhou Xiaoyan Li Pan Zhang Xiao‐Rong Sun Shankun Zhao

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate the effect of dihydroartemisinin (DHA) for enhancing the inhibitory effect of cisplatin (DDP) on DDP-resistant nasopharyngeal carcinoma cell line HNE1/DDP and explore the mechanism.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cong et al. (2024) studied this question.

synapsesocial.com/papers/68e5bb23b6db643587552f7d https://doi.org/10.12122/j.issn.1673-4254.2024.08.14

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways2024 · 12 citations
2Low-dose dihydroartemisinin resensitizes lung cancer cells to cisplatin by suppressing interleukin-6 release by macrophages.Original Research · 2026
3Dihydroartemisinin overcomes cisplatin resistance in bladder cancer via suppression of the PI3K/AKT/ABCB1 signaling AxisOriginal Research · 2026
4Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage2024 · 2 citations
5Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway2024 · 7 citations